Tags

Type your tag names separated by a space and hit enter

Willingness toward COVID-19 vaccination, coadministration with other vaccines and receive a COVID-19 vaccine booster: a cross-sectional study on the guardians of children in China.
Hum Vaccin Immunother. 2022 11 30; 18(5):2049169.HV

Abstract

This study aimed to investigate the changes in the willingness of guardians to administer the COVID-19 vaccine to their children, allow the coadministration of other vaccines, and administer the COVID-19 vaccine booster dose. This was a follow-up study conducted 6 months after a similar previous study. The self-administered questionnaire was distributed through the "Xiao Dou Miao" app and 9424 guardians with access to this app participated in the survey that was conducted from September 15 to October 8, 2021. Of all the participating guardians, 86.68% were willing to vaccinate their children with the COVID-19 vaccine, which was approximately 16% more than those in our previous study. Guardians aged ≥40 years, healthcare workers, and those with children aged ≥3 years were more willing to vaccinate their children. Approximately 77% of the guardians were willing toward the coadministration of COVID-19 and influenza vaccines. Approximately 64% of the guardians were willing toward the coadministration of other nonimmunization program vaccines with the COVID-19 vaccine for their children. The primary reasons for reluctance toward the coadministration of vaccines were concerns about vaccine safety and effectiveness. If necessary, 92% of the guardians were willing to receive a COVID-19 vaccine booster and 82% were willing to vaccinate their children with a COVID-19 vaccine booster. We hope that this research will facilitate the formulation of successful strategies for the implementation of COVID-19 vaccinations, covaccinations, and COVID-19 booster doses, particularly for children aged <6 years.

Links

PMC Free PDF

Authors+Show Affiliations

Ma L
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Institute of pharmaceutical and medical devices supervision, National Medical Products Administration-Chinese Academy of Medical Sciences, Beijing, China. Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Guilin Medical University, Guilin, China.
Yang J
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Zhang T
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Institute of pharmaceutical and medical devices supervision, National Medical Products Administration-Chinese Academy of Medical Sciences, Beijing, China.
Han X
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Huang Q
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Yang Y
Division of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.
Feng L
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Institute of pharmaceutical and medical devices supervision, National Medical Products Administration-Chinese Academy of Medical Sciences, Beijing, China.
Yang W
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Institute of pharmaceutical and medical devices supervision, National Medical Products Administration-Chinese Academy of Medical Sciences, Beijing, China.
Wang C
Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

MeSH

COVID-19COVID-19 VaccinesChildChinaCross-Sectional StudiesFollow-Up StudiesHumansImmunization, SecondaryInfluenza, HumanVaccination

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

35417663

Citation

Ma, Libing, et al. "Willingness Toward COVID-19 Vaccination, Coadministration With Other Vaccines and Receive a COVID-19 Vaccine Booster: a Cross-sectional Study On the Guardians of Children in China." Human Vaccines & Immunotherapeutics, vol. 18, no. 5, 2022, p. 2049169.
Ma L, Yang J, Zhang T, et al. Willingness toward COVID-19 vaccination, coadministration with other vaccines and receive a COVID-19 vaccine booster: a cross-sectional study on the guardians of children in China. Hum Vaccin Immunother. 2022;18(5):2049169.
Ma, L., Yang, J., Zhang, T., Han, X., Huang, Q., Yang, Y., Feng, L., Yang, W., & Wang, C. (2022). Willingness toward COVID-19 vaccination, coadministration with other vaccines and receive a COVID-19 vaccine booster: a cross-sectional study on the guardians of children in China. Human Vaccines & Immunotherapeutics, 18(5), 2049169. https://doi.org/10.1080/21645515.2022.2049169
Ma L, et al. Willingness Toward COVID-19 Vaccination, Coadministration With Other Vaccines and Receive a COVID-19 Vaccine Booster: a Cross-sectional Study On the Guardians of Children in China. Hum Vaccin Immunother. 2022 11 30;18(5):2049169. PubMed PMID: 35417663.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Willingness toward COVID-19 vaccination, coadministration with other vaccines and receive a COVID-19 vaccine booster: a cross-sectional study on the guardians of children in China. AU - Ma,Libing, AU - Yang,Jin, AU - Zhang,Ting, AU - Han,Xuan, AU - Huang,Qiangru, AU - Yang,Yuan, AU - Feng,Luzhao, AU - Yang,Weizhong, AU - Wang,Chen, Y1 - 2022/04/13/ PY - 2022/4/14/pubmed PY - 2022/6/15/medline PY - 2022/4/13/entrez KW - COVID-19 vaccine booster KW - Children KW - coadministration KW - willingness toward vaccination SP - 2049169 EP - 2049169 JF - Human vaccines & immunotherapeutics JO - Hum Vaccin Immunother VL - 18 IS - 5 N2 - This study aimed to investigate the changes in the willingness of guardians to administer the COVID-19 vaccine to their children, allow the coadministration of other vaccines, and administer the COVID-19 vaccine booster dose. This was a follow-up study conducted 6 months after a similar previous study. The self-administered questionnaire was distributed through the "Xiao Dou Miao" app and 9424 guardians with access to this app participated in the survey that was conducted from September 15 to October 8, 2021. Of all the participating guardians, 86.68% were willing to vaccinate their children with the COVID-19 vaccine, which was approximately 16% more than those in our previous study. Guardians aged ≥40 years, healthcare workers, and those with children aged ≥3 years were more willing to vaccinate their children. Approximately 77% of the guardians were willing toward the coadministration of COVID-19 and influenza vaccines. Approximately 64% of the guardians were willing toward the coadministration of other nonimmunization program vaccines with the COVID-19 vaccine for their children. The primary reasons for reluctance toward the coadministration of vaccines were concerns about vaccine safety and effectiveness. If necessary, 92% of the guardians were willing to receive a COVID-19 vaccine booster and 82% were willing to vaccinate their children with a COVID-19 vaccine booster. We hope that this research will facilitate the formulation of successful strategies for the implementation of COVID-19 vaccinations, covaccinations, and COVID-19 booster doses, particularly for children aged <6 years. SN - 2164-554X UR - https://www.unboundmedicine.com/medline/citation/35417663/Willingness_toward_COVID_19_vaccination_coadministration_with_other_vaccines_and_receive_a_COVID_19_vaccine_booster:_a_cross_sectional_study_on_the_guardians_of_children_in_China_ DB - PRIME DP - Unbound Medicine ER -